FDA Approved: RISPERIDONE — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved a supplemental application for risperidone from Natco Pharma USA LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Irritability Associated with Autistic Disorder
• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)